You just read:

Nouscom - IND for NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine, Cleared by FDA to Commence Clinical Development in MSI Solid Tumors

News provided by

Nouscom

Jun 03, 2019, 03:00 ET